2001
DOI: 10.1186/cc1185
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (Cmax)remain unaffected

Abstract: P2Model-based neuro-fuzzy control of FiO 2 for intensive care mechanical ventilation HF Kwok, GH Mills, M Mahfouf, DA Linkens Introduction: In our experience, very often, even with a nonrebreathing mask (NRM), high oxygen delivery to patient with the existent materials is insufficient. However, many of these patients need high oxygen therapy for a limited period of time. In this study we report our experience with a new device that serves to increase the concentration of oxygen delivered by a classical nasal … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
1
0
2

Year Published

2002
2002
2007
2007

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
1
0
2
Order By: Relevance
“…Hydroxyethyl starch metabolic products (threshold 40 000 Da) are excreted primarily through the kidneys (Foerster et al, 2001). HES improves kidney perfusion, as well as increases urine volumes and creatinine clearance, which means that a single infusion of HES can be given to geriatric patients with mild to severe renal failure (Jungheinrich et al, 2001). In controls, the specific gravity of urine increased following 5 and 10 ml/kg infusions of HES, although the concentration of urea and creatinine remained the same during the entire observation period.…”
Section: Discussionmentioning
confidence: 99%
“…Hydroxyethyl starch metabolic products (threshold 40 000 Da) are excreted primarily through the kidneys (Foerster et al, 2001). HES improves kidney perfusion, as well as increases urine volumes and creatinine clearance, which means that a single infusion of HES can be given to geriatric patients with mild to severe renal failure (Jungheinrich et al, 2001). In controls, the specific gravity of urine increased following 5 and 10 ml/kg infusions of HES, although the concentration of urea and creatinine remained the same during the entire observation period.…”
Section: Discussionmentioning
confidence: 99%
“…Dass das Ausmaû und die Geschwindigkeit der renalen Elimination von HES bei mäûiggradiger Nierenfunktionseinschränkung kaum vermindert werden, lässt sich aus Untersuchungen mit unterschiedlichen HES-Typen (HES 450/0,7, HES 130/0,4) ableiten [21,48]. Somit ist die in vorliegender Studie festgestellte ¾hnlichkeit der initialen Halbwertszeiten von HES 200/0,5 bei normaler und bei eingeschränkter Nierenfunktion durchaus in gutem Einklang mit der Erwartungshaltung.…”
Section: Ergebnisseunclassified
“…Untersuchungen bei terminaler Niereninsuffizienz sprechen für eine Existenz dieses Mechanismus [34]. Für HES 130/0,4 wurden jedoch bei mäûig eingeschränkter Nierenfunktion renale Wiederfindungsraten erhoben, die nur unwesentlich unter denen bei ungestörter Nierenfunktion lagen [48]. Auf vorliegende Studie projeziert würde das für eine tatsächliche Ausscheidung von HES 200/0,5 aus dem Körper ± und nicht für eine Umverteilung innerhalb des Körpers ± sprechen.…”
Section: Ergebnisseunclassified